| Dr Kalana Rene' Greer, PSYD | |
|
3454 Hillcrest Ave, Antioch, CA 94531-4263 | |
| (925) 777-6377 | |
| Not Available |
| Full Name | Dr Kalana Rene' Greer |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 3454 Hillcrest Ave, Antioch, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306498027 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY30947 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kalana Rene' Greer, PSYD 3454 Hillcrest Ave, Antioch, CA 94531-4263 Ph: (925) 777-6377 | Dr Kalana Rene' Greer, PSYD 3454 Hillcrest Ave, Antioch, CA 94531-4263 Ph: (925) 777-6377 |
News Archive
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today the signing of an exclusive worldwide licensing agreement for the development and co-commercialization of MM-121, a first-in-class, fully human monoclonal antibody designed to block signaling of the ErbB3 receptor. MM-121 is currently in Phase 1 clinical testing.
Dartmouth researchers have found that duration of ibuprofen use was associated with a reduced risk of bladder cancer in patients in northern New England, which has a high mortality rate of this disease. In a 2012 collaborative project with the National Cancer Institute, Margaret Karagas, PhD, co-director, Cancer Epidemiology & Chemoprevention program at Norris Cotton Cancer Center, and Professor of Community and Family Medicine at the Geisel School of Medicine at Dartmouth, and Richard Waddell, D.Sc, Research Assistant Professor of Medicine at the Geisel School of Medicine, looked for connections between ibuprofen use and bladder cancer.
Engaging in brief, cognitive-behavioral therapy is an effective treatment for helping people with problematic caffeine use lower their caffeine consumption, according to a new study coauthored by Laura M. Juliano, Ph.D., a professor of psychology at American University.
Adverse drug reactions are a major issue that cause harm, are costly and restrict treatment options for patients and the development of new drugs. A groundbreaking finding by researchers from the La Jolla Institute for Allergy & Immunology could lead to a new way to dramatically improve drug safety by identifying drugs at risk to cause potentially fatal genetic-linked hypersensitivity reactions before their use in man.
› Verified 1 days ago
Dr. Justin Low, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 509 W 10th St, Antioch, CA 94509 Phone: 209-244-6717 | |
Alexzander Ponce Diaz, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 509 W 10th St, Antioch, CA 94509 Phone: 650-270-0468 | |
Tracy Lefebvre Roulet, M.A Psychologist Medicare: Not Enrolled in Medicare Practice Location: 509 W 10th St, Antioch, CA 94509 Phone: 925-777-9540 | |
Dr. Deborah Kaplan, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 2213 Buchanan Rd, 203, Antioch, CA 94509 Phone: 925-779-4990 | |
Dr. John Sebastian Italia, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2213 Buchanan Rd Ste 203, Antioch, CA 94509 Phone: 925-779-4934 | |
Dr. Olayinka Rahman, Psychologist Medicare: Medicare Enrolled Practice Location: 3454 Hillcrest Ave, Antioch, CA 94531 Phone: 925-777-6300 | |
Jon Colladay, MFCC Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2225 Buchanan Rd, Suite H, Antioch, CA 94509 Phone: 925-753-1986 |